Common virus may serve as target for vaccine in fight against deadly brain tumors

By targeting a common virus, doctors may be able to extend the lives of patients diagnosed with the most prevalent and deadly type of brain tumor, according to a study led by researchers in Duke’s Preston Robert Tisch Brain Tumor Center.

If you want to include this story in your blog, copy and paste this formatted text: